Author(s):
Pradnya D. Lahamge, Yashpal M. More, Pallavi P. Ahire, Vinay R. Kothawade
Email(s):
lahamgepradnya@gmail.com
DOI:
10.52711/0975-4377.2024.00007 
Address:
Pradnya D. Lahamge, Yashpal M. More, Pallavi P. Ahire, Vinay R. Kothawade
Loknete Dr. J. D. Pawar College of Pharmacy, College in Manur, Maharashtra.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2024
ABSTRACT:
The category of gastroretentive drug delivery systems (GRDDS) includes floating drug delivery systems (FDDS). These dose formulations are intended to extend the duration of the stomach's residence period by a sustained release technique. Drugs which are harder to dissolve in high pH environments have improved bioavailability and solubility when incorporated into GRDDS. Reduced intestinal absorption of solid dose forms can be accomplished by the flotation mechanism. The novel fusion of bilayer and floating mechanism is demonstrated by the bilayer floating drug delivery device. It demonstrates the effective creation of a controlled release formulation. Bilayer floating tablets offer a sustained release layer formulation in addition to an immediate release. A attempt was made to explain the mechanism of FDDS, or floating bilayer, in the review. In order to accomplish regulated administration of various medications with predetermined release profiles, bi-layer tablets were developed. The pharmaceutical industry has been more interested in creating bilayer tablets over the past ten years as a way to improve patient compliance and convenience by combining two or more API in a single dose form.
Cite this article:
Pradnya D. Lahamge, Yashpal M. More, Pallavi P. Ahire, Vinay R. Kothawade. A Comprehensive Review on Floating Drug Delivery System. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(1):42-6. doi: 10.52711/0975-4377.2024.00007
Cite(Electronic):
Pradnya D. Lahamge, Yashpal M. More, Pallavi P. Ahire, Vinay R. Kothawade. A Comprehensive Review on Floating Drug Delivery System. Research Journal of Pharmaceutical Dosage Forms and Technology.2024; 16(1):42-6. doi: 10.52711/0975-4377.2024.00007 Available on: https://rjpdft.com/AbstractView.aspx?PID=2024-16-1-7
REFERENCES:
1. Bardonnet, P. L., Faivre, V., Pugh, W. J., Piffaretti, J. C., and Falson, F. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. In Journal of Controlled Release. 2006; 111( 1–2). https://doi.org/10.1016/j.jconrel.2005.10.031
2. Chourasiya, A., Gehalot, N., and Mahajan, S. C. A review on an emergin trend bilayer floating drug delivery system. Current Research in Pharmaceutical Sciences. 2021; 11(2): 44–49. https://doi.org/10.24092/CRPS.2021.110201
3. Dinakaran, S. K., Kumar, S., Banji, D., Avasarala, H., and Rao, V. (2011). Formulation and evaluation of bi-layer floating tablets of ziprasidone HCl and trihexyphenidyl HCl. Brazilian Journal of Pharmaceutical Sciences. 2011; 47(3): https://doi.org/10.1590/S1984-82502011000300012
4. Dube, T. S., Ranpise, N. S., and Ranade, A. N. Formulation and Evaluation of Gastroretentive Microballoons Containing Baclofen for a Floating Oral Controlled Drug Delivery System. Current Drug Delivery, 2014; 11(6). https://doi.org/10.2174/1567201811666140414113838
5. Hejazi, R., and Amiji, M. (2003). Chitosan-based gastrointestinal delivery systems. In Journal of Controlled Release. 2003; 89(2): https://doi.org/10.1016/S0168-3659(03)00126-3
6. Narendra, C., Srinath, M. S., and Babu, G. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech. 2006; 7(2). https://doi.org/10.1208/pt070234
7. Niharika, M. G., Krishnamoorthy, K., and Akkala, M. Overview on floating drug delivery system. In International Journal of Applied Pharmaceutics. 2018; 10(6). https://doi.org/10.22159/ijap.2018v10i6.28274
8. Pandey, A., Kumar, G., Kothiyal, P., and Barshiliya, Y. A Review on current approaches in gastro retentive drug delivery system. Asian Journal of Pharmacy and Medical Science. 2012; 2(4).
9. Parveen, S., Nawale, R. B., Shahi, S., Zadbuke, N. S., and Khan, S. (N.D.). European Journal of Pharmaceutical and Medical Research Floating Bilayer Tablet: A Review. www.ejpmr.com
10. Patel, M. R., Patel, A. A., Prajapati, L. M., and Patel, N. M. Intragastric floating drug delivery system of metformin hydrochloride as sustained release component and glimepiride as immidiate release component: Formulation and evaluation. International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4(SUPPL.3).
11. Reddy, L. H. V., and Murthy, R. S. R. Floating dosage systems in drug delivery. In Critical Reviews in Therapeutic Drug Carrier Systems. 2002; 19(6). https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v19.i6.20
12. Saikrishna, K. (N.D.). Floating bilayer drug delivery systems-a review of novel approach. EMCare Covered Journal Pharmanest An International Journal of Advances in Pharmaceutical Sciences. 5, 4. http://www.pharmanest.net
13. Salatin, S., Alami-Milani, M., Cilvegar, H., Fereidouni, S., Maghsoodi, M., Monajemzadeh, F., and Jelvehgari, M. Development and characterization of bilayered tablets of diazepam for oral drug delivery: design, optimization and in vitro evaluation. Therapeutic Delivery. 2022; 13(4). https://doi.org/10.4155/tde-2021-0077
14. Santhanalakshmi, G., Elango, K., Ramesh Kumar, K., and Farheen, F. Formulation and evaluation of bilayer floating tablets of trimetazidine hydrochloride and metoprolol succinate. Indian Journal of Pharmaceutical Education and Research, 46(3).
15. Shah SH, Patel JK, and Patel NV. (n.d.). Stomach specific floating drug delivery system: a review. In International Journal of PharmTech Research 2012; 1(3).
16. Singh, B. N., and Kim, K. H. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. In Journal of Controlled Release. 2002; 63(3). https://doi.org/10.1016/S0168-3659(99)00204-7
17. Strom, J. G. Book Review: An Introduction to Clinical Pharmaceutics. Annals of Pharmacotherapy. 2010; 44(9). https://doi.org/10.1345/aph.1p208
18. Whitehead, L., Fell, J. T., Collett, J. H., Sharma, H. L., and Smith, A. M. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. Journal of Controlled Release. 1998; 55(1). https://doi.org/10.1016/S0168-3659(97)00266-6
19. Wilson, C., Washington, N., and Washington, C. Physiological Pharmaceutics, Barriers to drug absorption, 2nd Edition. In Physiological Pharmaceutics. 2000
20. Wu, W., Zhou, Q., Zhang, H. B., Ma, G. D., and Fu, C. D. Studies on nimodipine sustained-release tablet capable of floating on gastric fluid with prolonged gastric resident time. Yaoxue Xuebao. 1997; 32(10).
21. Xu, X., Sun, M., Zhi, F., and Hu, Y. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. International Journal of Pharmaceutics. 2006; 310(1–2). https://doi.org/10.1016/j.ijpharm.2005.12.003